FDA Approved: REGADENOSON — Original Application (Hospira, Inc.)

View source ↗

Summary

FDA approved Hospira's Regadenoson as a generic (ANDA 214349) for use as a pharmacologic stress agent to detect myocardial ischemia in patients who cannot exerc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease

Drugs mentioned

• Regadenoson (Regadenoson)

Snippet

ORIG AP for REGADENOSON (REGADENOSON)